Neumora Therapeutics Inc (NMRA)

11.33 -0.01 (-0.09%) USD  |  NASDAQ  |  Dec 27, 16:00
11.33 0.00 (0.00%) After-Hours: 20:00
More

Neumora Therapeutics Enterprise Value: 1.489B for Dec. 27, 2024

Enterprise Value Chart

View Enterprise Value for NMRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
CEL-SCI Corp 37.91M
AIM ImmunoTech Inc 8.80M
IGC Pharma Inc 27.25M
NovaBay Pharmaceuticals Inc 2.098M
Protalix BioTherapeutics Inc 107.34M

Enterprise Value Related Metrics

Net Income (Quarterly) -72.55M
Total Expenses (Quarterly) 76.65M
EPS Diluted (Quarterly) -0.45
Earnings Yield -16.28%